Addressing data privacy, security and ethical challenges is essential for the responsible adoption of GenAI in healthcare: PwC India report
PwC
India introduces a comprehensive GenAI framework to guide healthcare providers
on how to adopt relevant business relevant use cases.
- GenAI
is revolutionising Indian healthcare, delivering better patient care,
diagnostic accuracy and operational efficiency.
- The
Indian GenAI market is expected to grow at a CAGR of 23.56% from 2024 to 2030.
- Collaborative
efforts, policy support and talent development are crucial for leveraging
GenAI’s full potential in healthcare.
Mumbai,
22nd March 2024: In a comprehensive analysis,
PwC India’s latest report, Understanding the impact of GenAI on the Indian
healthcare ecosystem’, provides an in-depth look at the transformative effects
and emerging challenges of generative artificial intelligence (GenAI) within
the Indian healthcare sector. This study highlights the revolutionary potential
of GenAI in enhancing patient care, streamlining healthcare operations,
advancing medical research and personalising treatment approaches.
The report underscores
significant advancements in healthcare delivery, showcasing how GenAI
facilitates improved diagnostic accuracy, operational efficiency and patient
engagement, ultimately leading to superior health outcomes. By leveraging
technologies such as natural language processing and predictive analytics,
GenAI stands at the forefront of a healthcare revolution, offering solutions
from real-time clinical decision support to personalised patient interaction
and care.
Arnab
Basu, Advisory Leader at PwC India, states, ‘Generative
AI is revolutionising the healthcare sector, offering unparalleled
opportunities for advancement and efficiency. Its impact spans from enhancing
patient care to streamlining operational processes, marking a significant leap
towards a technologically advanced healthcare system. Yet, to fully harness
GenAI’s capabilities, we must confront and navigate substantial challenges.
This includes adhering to ethical standards, safeguarding data privacy, and
ensuring inclusive and equitable technology deployment. Success hinges on
collaborative efforts across the healthcare ecosystem, uniting policymakers,
professionals and patients to foster a responsible and innovative healthcare
future.’
The journey of integrating
GenAI into healthcare poses its own set of challenges. The report addresses
critical issues such as data privacy, security and the ethical use of AI,
emphasising the need for comprehensive governance frameworks to mitigate risks
and ensure responsible deployment of GenAI technologies.
Amidst the rapid adoption of
GenAI, PwC India introduces a comprehensive framework tailored for the
healthcare sector, aiming to guide organisations through their digital
transformation journey. This framework emphasises the modernisation of data
systems, development of scalable AI solutions, and cultivation of a culture
that embraces technological advancement while addressing the nuances of
healthcare delivery.
Dr
Rana Mehta, Healthcare Leader at PwC India, adds, ‘As
we navigate this new era, it is crucial to balance technological advancement
with patient-centric values and ethical considerations. Our report aims to
serve as a roadmap for healthcare providers, policymakers, and technologists to
harness the benefits of GenAI effectively while prioritising patient safety and
data privacy.’
Sayantan
Chatterjee, Digital Healthcare Leader at PwC India,
adds, ‘With its ripple effect, GenAI is helping to bridge some of the inherent
lacunae in the Indian healthcare space and enabling delivery of better quality
care that is data driven, research led and places Indian patients at the
centre. And the current focus on patient health data driven by Ayushman Bharat
Digital Mission (ABDM) makes GenAI all the more pertinent to work towards a
universal health interface across the 1.4 billion population.
PwC’s report is a clarion
call for healthcare leaders to strategically adopt GenAI technologies,
advocating for a balanced approach that promotes innovation while ensuring
ethical, secure and equitable healthcare delivery. It highlights the sector’s
vast potential and outlines strategic recommendations to overcome existing
barriers, facilitating the smoother integration of GenAI into the healthcare
ecosystem.
About
PwC
At
PwC, our purpose is to build trust in society and solve important problems.
We’re a network of firms in 151 countries with over 360,000 people who are
committed to delivering quality in assurance, advisory and tax services. Find
out more and tell us what matters to you by visiting us at www.pwc.com.